Ahmad Tarhini, MD, Oncology, Tampa, FL, H. Lee Moffitt Cancer Center and Research Institute

AhmadTarhiniMDPhD

Oncology Tampa, FL

Hematologic Oncology, Melanoma

Director, Cutaneous Clinical and Translational Research

Overview of Dr. Tarhini

Dr. Ahmad Tarhini is an oncologist in Tampa, FL and is affiliated with multiple hospitals in the area, including H. Lee Moffitt Cancer Center and Research Institute, UPMC Presbyterian, UPMC Magee-Womens Hospital, and Shadyside Campus. Dr. Tarhini accepts several types of health insurance, listed below. He is one of 148 doctors at UPMC Presbyterian and one of 82 doctors at UPMC Magee-Womens Hospital who specialize in Oncology.

Education & Training

  • University of Pittsburgh Medical Center
    University of Pittsburgh Medical CenterFellowship, Hematology/Oncology, 2003 - 2006
  • University of Pittsburgh Medical Center
    University of Pittsburgh Medical CenterResidency, Internal Medicine, 2000 - 2003

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2019 - 2021
  • GA State Medical License
    GA State Medical License 2018 - 2020
  • OH State Medical License
    OH State Medical License 2017 - 2019
  • PA State Medical License
    PA State Medical License 2001 - 2018
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • United States Intergroup E1609: A phase III randomized study of adjuvant ipilimumab (3 or 10 mg/kg) versus high-dose interferon-α2b for resected high-risk melanoma. 
    2019 ASCO Annual Meeting - 6/1/2019
  • Clinical and economic outcomes associated with sequential treatment in BRAF mutant advanced melanoma patients. 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
  • Association of Community Cancer Centers(ACCC) 30th National Conference 
    Association of Community Cancer Centers (ACCC), Boston, Massachusetts - 10/2/2013
  • Join now to see all

Authored Content

  • Association of BRAF V600E/K Mutation Status and Prior BRAF/MEK Inhibition with Pembrolizumab Outcomes in Advanced MelanomaJuly 2020
  • Association of BRAF V600E/K Mutation Status and Prior BRAF/MEK Inhibition with Pembrolizumab Outcomes in Advanced MelanomaJuly 2020

Press Mentions

  • Should Nicotinamide Be Used for Melanoma Prevention?
    Should Nicotinamide Be Used for Melanoma Prevention?October 24, 2020 18:59
  • CURE’s Clinical Trial Corner: September 2020
    CURE’s Clinical Trial Corner: September 2020October 11, 2020 20:52
  • A One-Day Melanoma Refresh with Cleveland Clinic Experts
    A One-Day Melanoma Refresh with Cleveland Clinic ExpertsJuly 27, 2018 18:02
  • Join now to see all

Hospital Affiliations

Insurance Accepted

  • Aetna Choice POS II
    Aetna HMO
    BCBS Blue Card PPO
    BCBS Texas BlueChoice
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    Coventry Oklahoma
    First Choice
    First Health PPO
    Great West PPO
    Health Net Oregon PPO
    HealthAmerica HealthAssurance PPO
    Highmark BCBS ClassicBlue
    Highmark BCBS PPOBlue
    Humana ChoiceCare Network PPO
    Multiplan PHCS PPO
    Multiplan PPO
    ODS Network
    Providence Health System Personal Option
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment